about
A human CCT5 gene mutation causing distal neuropathy impairs hexadecamer assembly in an archaeal model.Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohortSleep Duration and Midday Napping with 5-Year Incidence and Reversion of Metabolic Syndrome in Middle-Aged and Older Chinese.Chaperonopathies and chaperonotherapy. Hsp60 as therapeutic target in cancer: potential benefits and risks.Hsp60, a novel target for antitumor therapy: structure-function features and prospective drugs design.Identification of circulating microRNAs during the liver neoplastic process in a murine model of hereditary tyrosinemia type 1.Synthesis and biological activities of a new class of heat shock protein 90 inhibitors, designed by energy-based pharmacophore virtual screening.Polymeric proanthocyanidins from Sicilian pistachio (Pistacia vera L.) nut extract inhibit lipopolysaccharide-induced inflammatory response in RAW 264.7 cells.Genome-Wide Analysis of DNA Methylation and Acute Coronary Syndrome.Heat shock response associated with hepatocarcinogenesis in a murine model of hereditary tyrosinemia type I.Corrigendum: Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort.In vitro digestion of betalainic foods. Stability and bioaccessibility of betaxanthins and betacyanins and antioxidative potential of food digesta.Trans-epithelial transport of the betalain pigments indicaxanthin and betanin across Caco-2 cell monolayers and influence of food matrix.Molecular Aspects of the FAH Mutations Involved in HT1 Disease.Molecular Pathogenesis of Liver Injury in Hereditary Tyrosinemia 1.Dose-response relationship between serum uric acid levels and risk of incident coronary heart disease in the Dongfeng-Tongji CohortMolecular changes associated with chronic liver damage and neoplastic lesions in a murine model of hereditary tyrosinemia type 1
P50
Q34404630-40ABD563-7DA9-4497-834B-2471E1632D15Q35848690-DFD52533-766F-44E2-8D99-4911F8F16C0AQ36793123-7286FB9C-86B8-44CB-BC6D-4FD0AD8CF4D1Q37351241-6274073E-068A-4314-A121-AA20F59872B0Q38037740-A4B44340-EE07-486B-A76F-0B670F8058ABQ38054858-DCFB6785-EDF0-4E1F-A2D8-E9B96BB90F5AQ38855609-C266471D-0F1B-476C-A040-8C4191D39368Q39177171-7F87ADB7-0281-4028-B2D0-08C5181A8343Q39511359-6953B8E1-5052-4D64-8980-1616FE9657CFQ40271462-34F572AC-7A75-417E-9395-A725146FB71AQ41457848-8B1D0915-1C7B-4539-B4FD-AA53AD6AE918Q42344665-9B0E7F15-A202-4A0C-A608-08E5F65ABFB1Q44573003-24D6F76F-853B-4D03-A61D-46FB28C4F2A1Q45047882-876C8333-490A-4B9C-B52E-999E0144334AQ48014395-6071053A-044B-4152-B5A4-E486B8838600Q50517224-E982CEEB-839E-4E17-94B6-6D1FE79BE058Q61989723-8DA1A533-7161-46CD-A1FD-9CCC4B9F9022Q61989730-0D6E21B3-045C-4C25-9CA0-3E52855A8DE0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesca Angileri
@ast
Francesca Angileri
@en
Francesca Angileri
@es
Francesca Angileri
@nl
Francesca Angileri
@sl
type
label
Francesca Angileri
@ast
Francesca Angileri
@en
Francesca Angileri
@es
Francesca Angileri
@nl
Francesca Angileri
@sl
prefLabel
Francesca Angileri
@ast
Francesca Angileri
@en
Francesca Angileri
@es
Francesca Angileri
@nl
Francesca Angileri
@sl
P106
P1153
55661027300
P21
P2798
P31
P496
0000-0002-7993-6965